BioNTech names ex-Sobi chief Guido Oelkers as CEO, succeeding Ugur Sahin - BNTX News | RalliesBioNTech names ex-Sobi chief Guido Oelkers as CEO, succeeding Ugur Sahin
B
BNTX• BioNTech appoints new chief executive
- BioNTech named Guido Oelkers as chief executive, set to take office by Feb. 1, 2027, succeeding co-founder Ugur Sahin.
- Oelkers joins from Swedish Orphan Biovitrum, where he has been CEO since 2017; he has 30+ years in biotech and pharma leadership.
- Chief Medical Officer Ozlem Tureci will move to the management of a new standalone company to be led with Sahin; a successor search is underway.
SHEL
•
